US5468612AExpiredUtility

9804 gene and methods of use thereof

Assignee: CYTOMED INCPriority: Nov 19, 1993Filed: Nov 19, 1993Granted: Nov 21, 1995
Est. expiryNov 19, 2013(expired)· nominal 20-yr term from priority
A61K 38/00C12Q 2600/158C07K 14/705C12Q 1/6876C07K 14/47
37
PatentIndex Score
9
Cited by
53
References
5
Claims

Abstract

A substantially pure preparation of a 9804 DNA encoding a hematopoietic stem cell protein; antibodies to the 9804 gene product; methods of purifying 9804-expressing cells; and methods of screening for 9804 homologs are disclosed.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A substantially pure preparation of a 9804 DNA having the sequence of SEQ ID NO:1. 
     
     
       2. A vector comprising the DNA of claim 1. 
     
     
       3. A cell containing the vector of claim 2. 
     
     
       4. A substantially pure DNA encoding a polypeptide which has the amino acid sequence of SEQ ID NO:2. 
     
     
       5. A method of screening for 9804 expression in a cell, which method comprises (a) contacting a gene transcript of a cell with the DNA of claim 5 at a temperature of at least 65° C.; and   (b) detecting hybridization of said DNA with said gene transcript, wherein hybridization of said DNA to said gene transcript indicates 9804 expression.

Join the waitlist — get patent alerts

Track US5468612A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.